Search company, investor...

Elion Eco

About Elion Eco

Elion Eco Provides solutions for ecological degradation. It is based in Chaoyang District, Beijing.

Headquarters Location

15 Guanghua Road 10th Floor, Building 1, Yili Ecological Plaza

Beijing, Beijing, 100020,


Missing: Elion Eco's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Elion Eco's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Elion Eco News

MiRxes, PT Elion to Develop Cancer Tests for Indonesian Population

Nov 29, 2022

Save for later NEW YORK – Singaporean biotechnology firm MiRxes said on Tuesday that it has reached an agreement with PT Elion Medika Indonesia to develop blood-based tests for the early detection of multiple cancers for the Indonesian market. As part of the arrangement, PT Elion will validate MiRxes' microRNA-based tests for stomach and lung cancer in an Indonesian cohort. The two companies have also established a joint project for creating a multi-cancer blood test based on miRNA and DNA methylation biomarkers found in Indonesian cancer patients. The partners will specifically focus on "high-incidence and high-mortality" cancers in the Indonesian population, including lung, breast, colorectal, liver, stomach, esophageal, ovarian, pancreatic, and prostate cancers. MiRxes CEO Lihan Zhou said that the deal with PT Elion is part of the company's quest to "bring accessible and affordable cancer early detection solutions" to Southeast Asia. The company announced partnerships with several Singapore universities and hospitals in July to study circulating microRNA and DNA methylation biomarkers for multi-cancer early detection. In its work with PT Elion, MiRxes will contribute its PCR and next-generation sequencing platforms, as well as its experience in developing and commercializing tests for the early detection of cancer. PT Elion, headquartered in Jakarta, will assist with local research, manufacturing, and clinical testing, and will engage Indonesian stakeholders, such as clinicians and policy makers. Talent development and manufacturing technology transfer are also part of the agreement. According to Nathan Tirtana, commissioner for PT Elion, the companies aim to develop a "high-quality and affordable multi-cancer early detection test and early intervention tailored to the Indonesian population." Together with Indonesian researchers, MiRxes and PT Elion will validate and optimize markers identified in European and Han Chinese cohorts in local cohorts representative of Indonesia's diverse population. More than 276 million people live in Indonesia, and the country has about 1,300 distinct ethnic groups. The Cadence-ID project will kick off next year, the companies said, and will involve the recruitment of more than 10,000 participants, including healthy, high risk, pre-cancerous and newly diagnosed cancer patients.

Elion Eco Frequently Asked Questions (FAQ)

  • Where is Elion Eco's headquarters?

    Elion Eco's headquarters is located at 15 Guanghua Road, Beijing.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.